UCP1 and amyotrophic lateral sclerosis: Consequently, if under ALS conditions the UCP activating threshold is much lower due to SNS hyperactivity, treatment with UCP inhibitors could interfere with the feedback circuit that maintain high UCP expression and in turn induces SNS activity.